electroCore, which is commercializing a handheld nerve stimulation device for treating migraines, raised $78 million by offering 5.2 million shares at $15, within the range of $14 to $16. electroCore plans to list on the Nasdaq under the symbol ECOR. Evercore ISI, Cantor Fitzgerald and JMP Securities acted as lead managers on the deal.
